Division of Cardiovascular Diseases, University of Kansas Hospital and Medical Center, Kansas City, Kansas.
Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
Heart Rhythm. 2018 Jul;15(7):1089-1096. doi: 10.1016/j.hrthm.2018.01.017. Epub 2018 Jan 8.
Left ventricular assist devices (LVAD) are increasingly used in the management of patients with advanced heart failure. Many of these patients have or will be considered for a cardiac implantable electronic device (CIED) such as an implantable cardioverter-defibrillator or a cardiac resynchronization therapy device. Frequent interplay is often encountered due to the complexity of these devices and the underlying disease states. Proactive management strategies and an awareness of interactions may help reduce adverse events. Here we review the current literature, present management recommendations, and discuss potential future investigations for CIEDs in patients with LVADs.
左心室辅助装置（LVAD）在心力衰竭患者的治疗中越来越多地被使用。这些患者中有许多已经或将要考虑使用心脏植入式电子设备（CIED），如植入式心脏除颤器或心脏再同步治疗设备。由于这些设备的复杂性和潜在的疾病状态，经常会遇到频繁的相互作用。积极的管理策略和对相互作用的认识可以帮助减少不良事件。在这里，我们回顾了当前的文献，提出了 CIED 在心衰患者中管理的建议，并讨论了潜在的未来研究方向。
